X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (269) 269
Patent (252) 252
Publication (34) 34
Conference Proceeding (3) 3
Magazine Article (2) 2
Book / eBook (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (130) 130
metallurgy (129) 129
human necessities (126) 126
hygiene (111) 111
medical or veterinary science (111) 111
organic chemistry (100) 100
preparations for medical, dental, or toilet purposes (98) 98
index medicus (91) 91
humans (84) 84
specific therapeutic activity of chemical compounds ormedicinal preparations (78) 78
microbiology (72) 72
heterocyclic compounds (62) 62
genotype (55) 55
hepacivirus - genetics (51) 51
biochemistry (47) 47
beer (45) 45
enzymology (45) 45
mutation or genetic engineering (45) 45
spirits (45) 45
vinegar (45) 45
wine (45) 45
hepatitis c virus (39) 39
virology (39) 39
general tagging of cross-sectional technologies spanning over several sections of the ipc (37) 37
general tagging of new technological developments (37) 37
hepatitis c (37) 37
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (37) 37
technologies or applications for mitigation or adaptation againstclimate change (37) 37
female (36) 36
hepacivirus - drug effects (36) 36
male (34) 34
antiviral agents (33) 33
pharmacology & pharmacy (33) 33
sofosbuvir (32) 32
performing operations (31) 31
transporting (31) 31
technologies for adaptation to climate change (30) 30
culture media (29) 29
gastroenterology & hepatology (29) 29
physics (29) 29
compositions thereof (28) 28
hepatitis (28) 28
hepatitis c, chronic - drug therapy (28) 28
microorganisms or enzymes (28) 28
propagating, preserving or maintaining microorganisms (28) 28
middle aged (26) 26
ribavirin (26) 26
peptides (25) 25
viral nonstructural proteins - genetics (25) 25
animals (24) 24
antiviral agents - pharmacology (24) 24
antiviral agents - therapeutic use (24) 24
genetic aspects (24) 24
measuring (24) 24
testing (24) 24
treatment outcome (24) 24
viral nonstructural proteins - antagonists & inhibitors (24) 24
adult (23) 23
infectious diseases (23) 23
mutation (23) 23
resistance (23) 23
investigating or analysing materials by determining theirchemical or physical properties (22) 22
hcv (21) 21
aged (20) 20
drug resistance, viral - genetics (20) 20
hepatitis c, chronic - virology (20) 20
drug resistance, viral (19) 19
in-vitro (19) 19
replication (19) 19
drug therapy, combination (18) 18
genotype & phenotype (18) 18
health aspects (18) 18
genotypes (17) 17
infection (17) 17
interferon (17) 17
agriculture (16) 16
cell line (16) 16
derivatives thereof (16) 16
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (16) 16
hepatitis c - virology (16) 16
ledipasvir (16) 16
patients (16) 16
virus diseases (16) 16
animal husbandry (15) 15
antiviral agents - administration & dosage (15) 15
fishing (15) 15
forestry (15) 15
hepatitis c - drug therapy (15) 15
hunting (15) 15
trapping (15) 15
viruses (15) 15
compositions or test papers therefor (14) 14
condition-responsive control in microbiological orenzymological processes (14) 14
gastroenterology and hepatology (14) 14
hepacivirus - classification (14) 14
measuring or testing processes involving enzymes, nucleicacids or microorganisms (14) 14
mice (14) 14
plus ribavirin (14) 14
processes of preparing such compositions (14) 14
analysis (13) 13
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (481) 481
Chinese (109) 109
French (39) 39
Spanish (16) 16
German (11) 11
Korean (6) 6
Portuguese (4) 4
Russian (4) 4
Romanian (3) 3
Japanese (2) 2
Moldavian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 6, pp. 645 - 653
Summary Background Compared with other countries, patients with chronic hepatitis C infection in Japan tend to be older, have more advanced liver disease, and... 
Infectious Disease | INFECTIOUS DISEASES | SIMEPREVIR | INFECTION | CHRONIC HCV | Uridine Monophosphate - administration & dosage | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Benzimidazoles - administration & dosage | Time Factors | Ribavirin - administration & dosage | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Hepacivirus - isolation & purification | Administration, Oral | Japan | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Asian Continental Ancestry Group | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Liver | Dosage and administration | Product development | Drug therapy, Combination | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Hepatitis | Genotype & phenotype | Liver cancer | Heart attacks | Liver diseases | Human immunodeficiency virus--HIV | Hepatology | Response rates | Interferon | Infections | Drug dosages | Patients
Journal Article
翠苑, ISSN 1005-5282, 2017, Issue 6, pp. 77 - 79
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 401 - 408
Summary Background Protease inhibitors have improved treatment of infection with hepatitis C virus (HCV), but dosing, a low barrier to resistance, drug... 
Infectious Disease | PSI-7977 | INFECTIOUS DISEASES | PLUS RIBAVIRIN | VIRUS-INFECTION | TELAPREVIR | BOCEPREVIR | INHIBITORS | Recombinant Proteins - therapeutic use | Uridine Monophosphate - administration & dosage | Nausea - chemically induced | Humans | Middle Aged | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Male | Secondary Prevention | Polyethylene Glycols - therapeutic use | Young Adult | Time Factors | Ribavirin - administration & dosage | Adult | Female | Headache - chemically induced | Uridine Monophosphate - therapeutic use | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | RNA, Viral - analysis | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Adolescent | Liver Cirrhosis - pathology | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Protease inhibitors | Proteases | Gastrointestinal diseases | Clinical trials | Product development | Genetic aspects | Interferon | Hepatitis C | Health aspects | Liver cirrhosis | Viral antigens
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 27, pp. 2608 - 2617
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 20, pp. 1889 - 1898
Journal Article
BMC pregnancy and childbirth, ISSN 1471-2393, 05/2019, Volume 19, Issue 1, pp. 188 - 9
Preeclampsia is associated with chronic inflammation. The cholinergic anti-inflammatory pathway regulates systemic inflammation through activating α7 nicotinic... 
Hypertension | Pregnancy | Proteins | Placenta | Cytokines | Womens health | Gynecology | Preeclampsia | Tumor necrosis factor-TNF | Protein expression | Blood pressure | Inflammation | NF-κB | α7nAChR
Journal Article